134 related articles for article (PubMed ID: 3311049)
1. Comparison of proteases from chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum.
Vander Jagt DL; Hunsaker LA; Campos NM
Biochem Pharmacol; 1987 Oct; 36(19):3285-91. PubMed ID: 3311049
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum.
Vander Jagt DL; Hunsaker LA; Campos NM
Mol Biochem Parasitol; 1986 Mar; 18(3):389-400. PubMed ID: 3515180
[TBL] [Abstract][Full Text] [Related]
3. Lysis of Plasmodium falciparum by ferriprotoporphyrin IX and a chloroquine-ferriprotoporphyrin IX complex.
Fitch CD; Chevli R; Banyal HS; Phillips G; Pfaller MA; Krogstad DJ
Antimicrob Agents Chemother; 1982 May; 21(5):819-22. PubMed ID: 7049079
[TBL] [Abstract][Full Text] [Related]
4. Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum.
vander Jagt DL; Hunsaker LA; Campos NM; Scaletti JV
Biochim Biophys Acta; 1992 Aug; 1122(3):256-64. PubMed ID: 1504087
[TBL] [Abstract][Full Text] [Related]
5. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
Famin O; Ginsburg H
Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
[TBL] [Abstract][Full Text] [Related]
6. Lysis of malarial parasites and erythrocytes by ferriprotoporphyrin IX-chloroquine and the inhibition of this effect by proteins.
Zhang Y; Hempelmann E
Biochem Pharmacol; 1987 Apr; 36(8):1267-73. PubMed ID: 3297071
[TBL] [Abstract][Full Text] [Related]
7. Hemoglobin catabolism and the killing of intraerythrocytic Plasmodium falciparum by chloroquine.
Orjih AU; Ryerse JS; Fitch CD
Experientia; 1994 Jan; 50(1):34-9. PubMed ID: 8293798
[TBL] [Abstract][Full Text] [Related]
8. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine uptake and activity is determined by binding to ferriprotoporphyrin IX in Plasmodium falciparum.
Bray PG; Janneh O; Ward SA
Novartis Found Symp; 1999; 226():252-60; discussion 260-4. PubMed ID: 10645550
[TBL] [Abstract][Full Text] [Related]
10. Hemozoin production by Plasmodium falciparum: variation with strain and exposure to chloroquine.
Orjih AU; Fitch CD
Biochim Biophys Acta; 1993 Jul; 1157(3):270-4. PubMed ID: 8323956
[TBL] [Abstract][Full Text] [Related]
11. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
Meierjohann S; Walter RD; Müller S
Biochem J; 2002 Dec; 368(Pt 3):761-8. PubMed ID: 12225291
[TBL] [Abstract][Full Text] [Related]
12. Parasite proteases and antimalarial activities of protease inhibitors.
Vander Jagt DL; Caughey WS; Campos NM; Hunsaker LA; Zanner MA
Prog Clin Biol Res; 1989; 313():105-18. PubMed ID: 2675111
[No Abstract] [Full Text] [Related]
13. Novel phenothiazine antimalarials: synthesis, antimalarial activity, and inhibition of the formation of beta-haematin.
Kalkanidis M; Klonis N; Tilley L; Deady LW
Biochem Pharmacol; 2002 Mar; 63(5):833-42. PubMed ID: 11911834
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P-450 activity in malarial parasites and its possible relationship to chloroquine resistance.
Ndifor AM; Ward SA; Howells RE
Mol Biochem Parasitol; 1990 Jun; 41(2):251-7. PubMed ID: 2204831
[TBL] [Abstract][Full Text] [Related]
15. Vacuolar acidification and chloroquine sensitivity in Plasmodium falciparum.
Bray PG; Howells RE; Ward SA
Biochem Pharmacol; 1992 Mar; 43(6):1219-27. PubMed ID: 1562274
[TBL] [Abstract][Full Text] [Related]
16. A Redox-Active Fluorescent pH Indicator for Detecting Plasmodium falciparum Strains with Reduced Responsiveness to Quinoline Antimalarial Drugs.
Jida M; Sanchez CP; Urgin K; Ehrhardt K; Mounien S; Geyer A; Elhabiri M; Lanzer M; Davioud-Charvet E
ACS Infect Dis; 2017 Feb; 3(2):119-131. PubMed ID: 28183182
[TBL] [Abstract][Full Text] [Related]
17. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance.
Hayward R; Saliba KJ; Kirk K
J Cell Sci; 2006 Mar; 119(Pt 6):1016-25. PubMed ID: 16492710
[TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a hemoglobin degrading aspartic protease from the malarial parasite Plasmodium vivax.
Sharma A; Eapen A; Subbarao SK
J Biochem; 2005 Jul; 138(1):71-8. PubMed ID: 16046450
[TBL] [Abstract][Full Text] [Related]
19. A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance.
Lakshmanan V; Bray PG; Verdier-Pinard D; Johnson DJ; Horrocks P; Muhle RA; Alakpa GE; Hughes RH; Ward SA; Krogstad DJ; Sidhu AB; Fidock DA
EMBO J; 2005 Jul; 24(13):2294-305. PubMed ID: 15944738
[TBL] [Abstract][Full Text] [Related]
20. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
